367 related articles for article (PubMed ID: 25927679)
21. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature.
Diamantis E; Kyriakos G; Quiles-Sanchez LV; Farmaki P; Troupis T
Curr Cardiol Rev; 2017; 13(3):209-216. PubMed ID: 28462692
[TBL] [Abstract][Full Text] [Related]
22. Inflammation, C-reactive protein, and atherothrombosis.
Ridker PM; Silvertown JD
J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
[TBL] [Abstract][Full Text] [Related]
23. Physical Activity in the Prevention and Treatment of Coronary Artery Disease.
Winzer EB; Woitek F; Linke A
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437600
[No Abstract] [Full Text] [Related]
24. [A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].
Fischer T
Orv Hetil; 2009 Mar; 150(11):503-12. PubMed ID: 19258246
[TBL] [Abstract][Full Text] [Related]
25. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.
Biasucci LM; Biasillo G; Stefanelli A
Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311
[TBL] [Abstract][Full Text] [Related]
27. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
[TBL] [Abstract][Full Text] [Related]
28. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
29. Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10).
Miyata R; Hiraiwa K; Cheng JC; Bai N; Vincent R; Francis GA; Sin DD; Van Eeden SF
Toxicol Appl Pharmacol; 2013 Oct; 272(1):1-11. PubMed ID: 23756175
[TBL] [Abstract][Full Text] [Related]
30. [Statins and brain protection mechanisms].
Tapia-Perez H; Sanchez-Aguilar M; Torres-Corzo J; Rodriguez-Leyva I; Herrera-Gonzalez LB
Rev Neurol; 2007 Sep 16-30; 45(6):359-64. PubMed ID: 17899518
[TBL] [Abstract][Full Text] [Related]
31. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
[TBL] [Abstract][Full Text] [Related]
32. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.
Kilic U; Gok O; Elibol-Can B; Uysal O; Bacaksiz A
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):321-30. PubMed ID: 25582759
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory markers in coronary artery disease.
Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
[TBL] [Abstract][Full Text] [Related]
36. Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosis.
Chilton RJ
J Am Osteopath Assoc; 2001 Sep; 101(9 Suppl):S1-5. PubMed ID: 11575041
[TBL] [Abstract][Full Text] [Related]
37. Effects of statins on endothelium and endothelial progenitor cell recruitment.
Walter DH; Dimmeler S; Zeiher AM
Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319
[TBL] [Abstract][Full Text] [Related]
38. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
39. Effects of statins beyond lipid lowering: potential for clinical benefits.
Almuti K; Rimawi R; Spevack D; Ostfeld RJ
Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
[TBL] [Abstract][Full Text] [Related]
40. [Statins and antiplatelet agents: complementary mechanisms of action at the coronary artery level].
Chapman J
Am J Cardiovasc Drugs; 2007; 7 Spec No 1():5-8. PubMed ID: 19839181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
